Phase II Trial of Dalantercept to Treat Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
This study is currently recruiting participants.
Verified May 2013 by Gynecologic Oncology Group
Sponsor:
Gynecologic Oncology Group
Collaborators:
Acceleron Pharma, Inc.
Information provided by (Responsible Party):
Gynecologic Oncology Group
ClinicalTrials.gov Identifier:
NCT01720173
First received: October 30, 2012
Last updated: May 7, 2013
Last verified: May 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | October 2015 (Final data collection date for primary outcome measure) |